Improving arteriovenous fistula patency: Transdermal delivery of diclofenac reduces cannulation-dependent neointimal hyperplasia via AMPK activation

Creation of an autologous arteriovenous fistula (AVF) for vascular access in haemodialysis is the modality of choice. However neointimal hyperplasia and loss of the luminal compartment result in AVF patency rates of ~ 60% at 12 months. The exact cause of neointimal hyperplasia in the AVF is poorly u...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vascul Pharmacol
Hlavní autoři: MacAskill, Mark G., Watson, David G., Ewart, Marie-Ann, Wadsworth, Roger, Jackson, Andrew, Aitken, Emma, MacKenzie, Graeme, Kingsmore, David, Currie, Susan, Coats, Paul
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier Science 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534710/
https://ncbi.nlm.nih.gov/pubmed/25866325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vph.2015.02.012
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky